Clinical trial
CREST-I: Resperine, Gabapentin, or Lamotrigine vs. Placebo
NCT00015106 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CREST-I: Resperine, Gabapentin, or Lamotrigine vs. Placebo
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 1997
- Completion date
- February 28, 1999
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.